Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice

Journal of Cellular Physiology

Volumn 219, Issue 2, 2009, Pages 477-484

  Bruzzone, Ariana ^a   Vanzulli, Silvia Inés ^b   Soldati, Rocío ^a   Giulianelli, Sebastián ^a   Lanari, Claudia ^a   Lüthy, Isabel Alicia ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; STEROID HORMONE; STEROID RECEPTOR; TAMOXIFEN; ANTIESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR EMBOLISM; TUMOR GROWTH; UTERUS METASTASIS; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CULTURE TECHNIQUE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; HUMAN; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALIA; MUS; MUS MUSCULUS;

ANIMALS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TAMOXIFEN; TRANSPLANTATION, HETEROLOGOUS;

EID: 62149104792     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21694     Document Type: Article

References (46)

1. Allan AL, George R, Vantyghem SA, Lee MW, Hodgson NC, Engel CJ, Holliday RL, Girvan DP, Scott LA, Postenka CO, Al Katib W, Stitt LW, Uede T, Chambers AF, Tuck AB. 2006. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol 169:233-246.
2. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, Chow LW, Masood S, Ramsey SD, Carlson RW. 2006. Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 guidelines. Breast J 12:S3-S15.
3. Arpino G, Gutierrez C, Weiss H, Rimawi M, Massarweh S, Bharwani L, De Placido S, Osborne CK, Schiff R. 2007. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. J Natl Cancer Inst 99:694-705.
4. Bandyopadhyay A, Wang L, Chin SH, Sun LZ. 2007. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines. Neoplasia 9:113-118.
5. Bruzzone A, Pinero CP, Castillo LF, Sarappa MG, Rojas P, Lanari C, Luthy IA. 2008. alpha(2)-Adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 155:494-504.
6. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. 1996. MCF10AT: A model for the evolution of cancer from proliferative breast disease. Am J Pathol 148:313-319.
7. Dowdy S, Wearden S. 1983. Statistics for research. New York: John Wiley & Sons, Inc.
8. Gonzalez L, Agullo-Ortuno MT, Garcia-Martinez JM, Calcabrini A, Gamallo C, Palacios J, Aranda A, Martin-Perez J. 2006. Role of c-Src in human MCF7 breast cancer cell tumorigenesis. J Biol Chem 281:20851-20864.
9. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C. 2007. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 67:2062-2071.
10. Halpern M, Zahalka MA, Traub L, Moroz C. 2007. Antibodies to placental immunoregulatory ferritin with transfer of polyclonal lymphocytes arrest MCF-7 human breast cancer growth in a nude mouse model. Neoplasia 9:487-494.
11. Harrell JC, Dye WW, Allred DC, Jedlicka P, Spoelstra NS, Sartorius CA, Horwitz KB. 2006. Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res 66:9308-9315.
12. Harvell DM, Richer JK, Allred DC, Sartorius CA, Horwitz KB. 2006. Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture. Endocrinology 147:700-713.
13. Hortobagyi GN, de la Garza SJ, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O'Shaughnessy JA, Shen ZZ, Albain KS. 2005. The global breast cancer burden: Variations in epidemiology and survival. Clin Breast Cancer 6:391-401.
14. Huang Y, Fernandez SV, Goodwin S, Russo PA, Russo IH, Sutter TR, Russo J. 2007. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67:11147-11157.
15. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. 2007. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213:374-383.
16. Iliopoulos D, Fabbri M, Druck T, Qin HR, Han SY, Huebner K. 2007. Inhibition of breast cancer cell growth in vitro and in vivo: Effect of restoration of Wwox expression. Clin Cancer Res 13:268-274.
17. Institute of Laboratory Animal Resources Commission on Life National Research. 1996. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
18. Kasper G, Reule M, Tschirschmann M, Dankert N, Stout-Weider K, Lauster R, Schrock E, Mennerich D, Duda GN, Lehmann KE. 2007. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: Involvement of the IGF-1 signalling pathway. BMC Cancer 7:12.
19. Lamb CA, Helguero LA, Fabris V, Lucas C, Molinolo AA, Lanari C. 2003. Differential effects of raloxifene, tamoxifen and fulvestrant on a murinemammary carcinoma. Breast Cancer Res Treat 79:25-35.
20. Lamb CA, Helguero LA, Giulianelli S, Soldati R, Vanzulli SI, Molinolo A, Lanari C. 2005. Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice. Breast Cancer Res 7:R1111-R1121.
21. Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA. 2001. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: In vivo and in vitro effects of estrogens and progestins. Cancer Res 61:293-302.
22. Leclercq G. 2002. Molecular forms of the estrogen receptor in breast cancer. J Steroid Biochem Mol Biol 80:259-272.
23. Li D, Mitchell D, Luo J, Yi Z, Cho SG, Guo J, Li X, Ning G, Wu X, Liu M. 2007. Estrogen regulates KiSS1 gene expression through estrogen receptor alpha and SP protein complexes. Endocrinology 148:4821-4828.
24. Liang Y, Besch-Williford C, Brekken RA, Hyder SM. 2007. Progestin-dependent progression of human breast tumor xenografts: A novel model for evaluating antitumor therapeutics. Cancer Res 67:9929-9936.
25. Martinelli M, Bonezzi K, Riccardi E, Kuhn E, Frapolli R, Zucchetti M, Ryan AJ, Taraboletti G, Giavazzi R. 2007. Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. Br J Cancer 97:888-894.
26. Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P. 2005. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis. Cancer Res 65:3493-3496.
27. Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, Liu M. 2006. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. J Biol Chem 281:51-58.
28. Montero GG, Vanzulli SI, Cerliani JP, Bottino MC, Bolado J, Vela J, Becu-Villalobos D, Benavides F, Gutkind S, Patel V, Molinolo AA, Lanari C. 2007. Association of estrogen receptor alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment. Breast Cancer Res 9:R22.
29. Nguyen DX, Massague J. 2007. Genetic determinants of cancer metastasis. Nat Rev Genet 8:341-352.
30. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348.
31. Parkin DM. 2004. International variation. Oncogene 23:6329-6340.
32. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
33. Paulus P, Stanley ER, Schafer R, Abraham D, Aharinejad S. 2006. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res 66:4349-4356.
34. Pecorelli S, Favalli G, Zigliani L, Odicino F. 2003. Cancer in women. Int J Gynaecol Obstet 82:369-379.
35. Scaltriti M, Rojo F, Ocana A, Anido J, Guzman M, Cortes J, Di Cosimo S, Matias-Guiu X, Cajal S, Arribas J, Baselga J. 2007. Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. J Natl Cancer Inst 99:628-638.
36. Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman ME. 1983. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 43:2223-2239.
37. Shafie SM, Grantham FH. 1981. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67:51-56.
38. Shafie SM, Liotta LA. 1980. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett 11:81-87.
39. Stuart EC, Rosengren RJ. 2008. The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells. Life Sci 82:943-948.
40. Tang B, Yoo N, Vu M, Mamura M, Nam JS, Ooshima A, Du Z, Desprez PY, Anver MR, Michalowska AM, Shih J, Parks WT, Wakefield LM. 2007. Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res 67:8643-8652.
41. Vargo-Gogola T, Rosen JM. 2007. Modelling breast cancer: One size does not fit all. Nat Rev Cancer 7:659-672.
42. Vazquez SM, Mladovan A, Garbovesky C, Baldi A, Luthy IA. 2004. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: Functional characterization. J Cell Physiol 199:460-469.
43. Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A. 2006. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res 66:11462-11470.
44. Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC. 2000. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res 6:2028-2036.
45. Zhang Y, Pu X, Shi M, Chen L, Qian L, Song Y, Yuan G, Zhang H, Yu M, Hu M, Shen B, Guo N. 2007a. c-Jun, a crucial molecule in metastasis of breast cancer and potential target for biotherapy. Oncol Rep 18:1207-1212.
46. Zhang Y, Pu X, Shi M, Chen L, Song Y, Qian L, Yuan G, Zhang H, Yu M, Hu M, Shen B, Guo N. 2007b. Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model. BMC Cancer 7:145.